Aurora Cannabis (TSE:ACB) Stock Price Up 19.9% – What’s Next?

Aurora Cannabis Inc. (TSE:ACB)’s share price rose 19.9% during trading on Tuesday. The company traded as high as C$7.20 and last traded at C$7.06. 1,969,414 shares changed hands during mid-day trading, an increase of 382% from the average session volume of 408,543 shares. The stock had previously closed at C$5.89.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. ATB Cormark Capital Markets lifted their price objective on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a “tender” rating in a research note on Tuesday, October 6th. TD downgraded shares of Aurora Cannabis from a “buy” rating to a “sell” rating and dropped their target price for the stock from C$8.00 to C$7.80 in a research report on Wednesday. TD Securities lowered shares of Aurora Cannabis from a “strong-buy” rating to a “strong sell” rating in a report on Tuesday. Finally, BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Aurora Cannabis has a consensus rating of “Reduce” and an average price target of C$6.60.

Aurora Cannabis Price Performance

The company has a 50-day moving average price of C$5.79 and a two-hundred day moving average price of C$4.95. The company has a debt-to-equity ratio of 4.30, a current ratio of 5.36 and a quick ratio of 2.48. The company has a market cap of C$461.53 million, a PE ratio of -3.76 and a beta of 0.26.

Aurora Cannabis (TSE:ACB) last announced its earnings results on Thursday, November 5th. The company reported C$0.05 EPS for the quarter. The business had revenue of C$86.02 million for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. Sell-side analysts expect that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.